doi: 10.1002/jso.27016. Online ahead of print. 1 Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA. 2 Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 3 Surgical and Perioperative Care, Atlanta VA Health Care System, Decatur, Georgia, USA.
Conclusions: NAT is associated with improved survival for GC, but it seems to be contingent on treatment response among patients with intermediate-stage disease.